Detalhe da pesquisa
1.
Lock-in amplifier based peak force infrared microscopy.
Analyst
; 148(2): 227-232, 2023 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36537473
2.
Fourier-Transform Atomic Force Microscope-Based Photothermal Infrared Spectroscopy with Broadband Source.
Nano Lett
; 22(22): 9174-9180, 2022 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368003
3.
Dual-Color Peak Force Infrared Microscopy.
Anal Chem
; 94(2): 1425-1431, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34962371
4.
Nanoarrays of Individual Liposomes and Bacterial Outer Membrane Vesicles by Liftoff Nanocontact Printing.
Small
; 17(50): e2103338, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655160
5.
Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha.
Clin Gastroenterol Hepatol
; 18(1): 196-204.e8, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31042581
6.
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China.
BMC Gastroenterol
; 19(1): 65, 2019 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31046700
7.
The Soft Tissue Angular Analysis of Facial Profile in Unoperated Adult Patients with Unilateral Cleft Palate.
Aesthetic Plast Surg
; 43(4): 982-992, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963186
8.
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China.
J Gastroenterol Hepatol
; 33(6): 1168-1176, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29380415
9.
Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON).
J Infect Dis
; 215(7): 1085-1093, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329061
10.
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues.
Gut
; 65(2): 313-20, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25586058
11.
Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study.
J Hepatol
; 65(4): 674-682, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27238752
12.
Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study).
Hepatology
; 61(5): 1512-22, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25348661
13.
HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients.
Virol J
; 13(1): 180, 2016 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27793166
14.
Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naïve patients in China and South Korea.
J Gastroenterol Hepatol
; 31(5): 912-20, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26777137
15.
Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B.
Liver Int
; 35(2): 473-81, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24517415
16.
[The efficacy and prognostic predictors of different treatment courses with pegylated interferon α-2a and ribavirin combination in recurrent chronic hepatitis C patients].
Zhonghua Nei Ke Za Zhi
; 54(8): 699-704, 2015 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-26674626
17.
[Clinical profiles of circulating plasmacytoid dendritic cells in chronic hepatitis B patients in response to pegylated-interferon alfa-2a treatment].
Zhonghua Gan Zang Bing Za Zhi
; 23(1): 34-9, 2015 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-25751384
18.
A randomized, open-label clinical study of combined pegylated interferon Alfa-2a (40KD) and entecavir treatment for hepatitis B "e" antigen-positive chronic hepatitis B.
Clin Infect Dis
; 59(12): 1714-23, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25190434
19.
Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels.
Hepatology
; 58(3): 872-80, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23553752
20.
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection.
BMC Gastroenterol
; 14: 47, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24625322